pelevina-art.ru


Supernus Pharmaceuticals Stock

Supernus Pharmaceuticals Inc. ; Prev. Close. ; Low. ; 52wk Low. ; Market Cap. b ; Total Shares. m. Supernus Pharmaceuticals, Inc. (pelevina-art.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Supernus Pharmaceuticals. View today's Supernus Pharmaceuticals Inc stock price and latest SUPN news and analysis. Create real-time notifications to follow any changes in the live. View live Supernus Pharmaceuticals, Inc. chart to track its stock's price action. Find market predictions, SUPN financials and market news. Year End Stock Prices · · · · · Year.

Supernus Pharmaceuticals, Inc.'s latest quarterly earnings per share is $ with a past EPS surprise of $ The latest EPS estimate is $ Read more. Supernus Pharmaceuticals (SUPN) has a Smart Score of 5 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. Supernus Pharmaceuticals to Announce Second Quarter Financial Results and Host Conference Call on August 8, ROCKVILLE, Md., July 24, (GLOBE. Supernus Pharmaceuticals Inc (SUPN) US$ ; Open · $ ; Trade high · $ ; Year high · $ ; Previous close · $ ; Trade low · $ Supernus Pharmaceuticals Inc. research and ratings by Barron's. View SUPN revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. 22 minutes ago. Discover real-time Supernus Pharmaceuticals, Inc. Common Stock (SUPN) stock prices, quotes, historical data, news, and Insights for informed trading and. Supernus Pharmaceuticals Inc's market capitalization is $ B by M shares outstanding. Is Supernus Pharmaceuticals stock a Buy, Sell or Hold? Supernus.

PROFILE (SUPN). Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. SUPN | Complete Supernus Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. SUPN. Supernus Pharmaceuticals, Inc. % ; GYRE. Gyre Therapeutics Inc. % ; SLNO. Soleno Therapeutics Inc. % ; TARO. Taro Pharmaceutical Industries Ltd. Research Supernus Pharmaceuticals' (Nasdaq:SUPN) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth. Get Supernus Pharmaceuticals Inc (SUPN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Supernus Pharmaceuticals ; Market Cap. $B ; P/E Ratio (ttm). N/A ; Forward P/E · ; Diluted EPS (ttm). ; Dividends Per Share. N/A. 58 minutes ago. The average price target for Supernus Pharmaceuticals is $ This is based on 2 Wall Streets Analysts month price targets, issued in the past 3 months. Innoviva Inc. $ INVA % ; In the news. pelevina-art.ru Canada. 1 day ago. Earnings call: Supernus Pharmaceuticals reports growth despite challenges By.

As of March 4, , SUPN stock price declined to $ with , million shares trading. What is Supernus Pharmaceuticals's Beta? 49 minutes ago. Stay up-to-date on Supernus Pharmaceuticals, Inc. Common Stock (SUPN) news with the latest updates, breaking headlines, news articles, and more from around. Looking ahead, we forecast Supernus Pharmaceuticals to be priced at by the end of this quarter and at in one year, according to Trading Economics. As of March 5, , SUPN stock price declined to $ with , million shares trading. What is Supernus Pharmaceuticals's Beta?

Stocks to Invest in 2022 LIVE - Supernus Pharmaceuticals - Stock analysis - Value investing

trading on pocket option | sql server sql tutorial

8 9 10 11 12

Copyright 2017-2024 Privice Policy Contacts